Global Anti-Peptic Ulcer Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Feb-2019
No. of pages: 116
Inquire Before Buying

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

China's anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China's homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China's healthcare needs are set to rise sharply in the coming years.

In April 2015, China amended its Drug Administration Law, introducing two major changes.

The first is a simplification of the company set-up procedure for pharmaceutical companies. Prior to the amendment, investors that wanted to manufacture or distribute pharmaceuticals needed to have a Drug Manufacturing License or a Drug Distribution License before applying for a business license. Now, investors may apply for these after the company has been set up, significantly speeding up the incorporation process.

More importantly, the amendment removes the price controls that the Chinese government had in place for medicines. As of the year 2000, medicines that were listed on the government's Medical Insurance Catalog, and those medicines on which there was a monopoly, had their prices fixed or guided by the government. About 23 percent of the medicines on the Chinese market had government fixed or guided prices. The price of other medicines was left to market forces. While these price restrictions are now fully removed, companies still need to abide by China's anti-trust laws. Companies abusing their dominant market position are still punishable under Chinese law.

While recent moves have made it easier for foreign investors to introduce new medical products to the Chinese market, the Chinese government has at the same time placed restraints on advertising healthcare products. The final text of the revised Advertising Law was released by the National People's Congress, China main legislative body, in late April 2015. The law comes into force in September 2015.

The 2015 Advertising Law has special stipulations about advertising for medicine and medical devices. For one, advertising for anesthetics, psychotropic drugs, toxic and radioactive drugs for medical use is not allowed, nor is advertisement for drugs, treatment plans and medical devices to combat drug addiction. Advertising for prescription drugs other than those mentioned previously is only allowed in professional medical journals.

The content for medical advertisements is regulated as well. Any advertisement for drugs, medical treatment or medical devices may not contain the following:

The global Anti-Peptic Ulcer Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Peptic Ulcer Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Anti-Peptic Ulcer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Peptic Ulcer Drugs in these regions.

This research report categorizes the global Anti-Peptic Ulcer Drugs market by top players/brands, region, type and end user. This report also studies the global Anti-Peptic Ulcer Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- AstraZeneca

- Ask-pharm

- Takeda

- Yangtze River Pharm

- Shandong Luoxin

- Huadong Medicine

- Changzhou Siyao

- Beijing Yuekang

- Guangdong Dahua

- Xian Janssen

Market size by Product

- Proton Pump Inhibitors (PPIs)

- Potassium-Competitive Acid Blockers (P-CAB)

- Antacids

- H2 Antagonists

- Ulcer Protective Drugs

Market size by End User

- Gastritis

- Gastric Ulcers

- Duodenal Ulcers

- Gastroesophageal Reflux Disease (GERD)

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Anti-Peptic Ulcer Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Anti-Peptic Ulcer Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Anti-Peptic Ulcer Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Anti-Peptic Ulcer Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-Peptic Ulcer Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Peptic Ulcer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Anti-Peptic Ulcer Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Anti-Peptic Ulcer Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Product
1.4.2 Proton Pump Inhibitors (PPIs)
1.4.3 Potassium-Competitive Acid Blockers (P-CAB)
1.4.4 Antacids
1.4.5 H2 Antagonists
1.4.6 Ulcer Protective Drugs
1.5 Market by End User
1.5.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by End User
1.5.2 Gastritis
1.5.3 Gastric Ulcers
1.5.4 Duodenal Ulcers
1.5.5 Gastroesophageal Reflux Disease (GERD)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Peptic Ulcer Drugs Market Size
2.1.1 Global Anti-Peptic Ulcer Drugs Revenue 2014-2025
2.1.2 Global Anti-Peptic Ulcer Drugs Sales 2014-2025
2.2 Anti-Peptic Ulcer Drugs Growth Rate by Regions
2.2.1 Global Anti-Peptic Ulcer Drugs Sales by Regions
2.2.2 Global Anti-Peptic Ulcer Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-Peptic Ulcer Drugs Sales by Manufacturers
3.1.1 Anti-Peptic Ulcer Drugs Sales by Manufacturers
3.1.2 Anti-Peptic Ulcer Drugs Sales Market Share by Manufacturers
3.1.3 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Peptic Ulcer Drugs Revenue by Manufacturers
3.2.1 Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Anti-Peptic Ulcer Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Anti-Peptic Ulcer Drugs Price by Manufacturers
3.4 Anti-Peptic Ulcer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Peptic Ulcer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Peptic Ulcer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Peptic Ulcer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-Peptic Ulcer Drugs Sales by Product
4.2 Global Anti-Peptic Ulcer Drugs Revenue by Product
4.3 Anti-Peptic Ulcer Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-Peptic Ulcer Drugs Breakdown Data by End User
6 North America
6.1 North America Anti-Peptic Ulcer Drugs by Countries
6.1.1 North America Anti-Peptic Ulcer Drugs Sales by Countries
6.1.2 North America Anti-Peptic Ulcer Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-Peptic Ulcer Drugs by Product
6.3 North America Anti-Peptic Ulcer Drugs by End User
7 Europe
7.1 Europe Anti-Peptic Ulcer Drugs by Countries
7.1.1 Europe Anti-Peptic Ulcer Drugs Sales by Countries
7.1.2 Europe Anti-Peptic Ulcer Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Peptic Ulcer Drugs by Product
7.3 Europe Anti-Peptic Ulcer Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Anti-Peptic Ulcer Drugs by Countries
8.1.1 Asia Pacific Anti-Peptic Ulcer Drugs Sales by Countries
8.1.2 Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-Peptic Ulcer Drugs by Product
8.3 Asia Pacific Anti-Peptic Ulcer Drugs by End User
9 Central & South America
9.1 Central & South America Anti-Peptic Ulcer Drugs by Countries
9.1.1 Central & South America Anti-Peptic Ulcer Drugs Sales by Countries
9.1.2 Central & South America Anti-Peptic Ulcer Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-Peptic Ulcer Drugs by Product
9.3 Central & South America Anti-Peptic Ulcer Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-Peptic Ulcer Drugs by Countries
10.1.1 Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Countries
10.1.2 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-Peptic Ulcer Drugs by Product
10.3 Middle East and Africa Anti-Peptic Ulcer Drugs by End User
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Ask-pharm
11.2.1 Ask-pharm Company Details
11.2.2 Company Business Overview
11.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Products Offered
11.2.5 Ask-pharm Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Company Business Overview
11.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Takeda Anti-Peptic Ulcer Drugs Products Offered
11.3.5 Takeda Recent Development
11.4 Yangtze River Pharm
11.4.1 Yangtze River Pharm Company Details
11.4.2 Company Business Overview
11.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Products Offered
11.4.5 Yangtze River Pharm Recent Development
11.5 Shandong Luoxin
11.5.1 Shandong Luoxin Company Details
11.5.2 Company Business Overview
11.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Products Offered
11.5.5 Shandong Luoxin Recent Development
11.6 Huadong Medicine
11.6.1 Huadong Medicine Company Details
11.6.2 Company Business Overview
11.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Products Offered
11.6.5 Huadong Medicine Recent Development
11.7 Changzhou Siyao
11.7.1 Changzhou Siyao Company Details
11.7.2 Company Business Overview
11.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Products Offered
11.7.5 Changzhou Siyao Recent Development
11.8 Beijing Yuekang
11.8.1 Beijing Yuekang Company Details
11.8.2 Company Business Overview
11.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Products Offered
11.8.5 Beijing Yuekang Recent Development
11.9 Guangdong Dahua
11.9.1 Guangdong Dahua Company Details
11.9.2 Company Business Overview
11.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Products Offered
11.9.5 Guangdong Dahua Recent Development
11.10 Xian Janssen
11.10.1 Xian Janssen Company Details
11.10.2 Company Business Overview
11.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Products Offered
11.10.5 Xian Janssen Recent Development
12 Future Forecast
12.1 Anti-Peptic Ulcer Drugs Market Forecast by Regions
12.1.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Regions 2019-2025
12.2 Anti-Peptic Ulcer Drugs Market Forecast by Product
12.2.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Product 2019-2025
12.3 Anti-Peptic Ulcer Drugs Market Forecast by End User
12.4 North America Anti-Peptic Ulcer Drugs Forecast
12.5 Europe Anti-Peptic Ulcer Drugs Forecast
12.6 Asia Pacific Anti-Peptic Ulcer Drugs Forecast
12.7 Central & South America Anti-Peptic Ulcer Drugs Forecast
12.8 Middle East and Africa Anti-Peptic Ulcer Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Peptic Ulcer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Anti-Peptic Ulcer Drugs Product Picture
Table Anti-Peptic Ulcer Drugs Market Segments
Table Key Manufacturers Anti-Peptic Ulcer Drugs Covered
Table Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Anti-Peptic Ulcer Drugs Sales Market Share by Product 2014-2025
Figure Proton Pump Inhibitors (PPIs) Product Picture
Table Major Manufacturers of Proton Pump Inhibitors (PPIs)
Figure Potassium-Competitive Acid Blockers (P-CAB) Product Picture
Table Major Manufacturers of Potassium-Competitive Acid Blockers (P-CAB)
Figure Antacids Product Picture
Table Major Manufacturers of Antacids
Figure H2 Antagonists Product Picture
Table Major Manufacturers of H2 Antagonists
Figure Ulcer Protective Drugs Product Picture
Table Major Manufacturers of Ulcer Protective Drugs
Table Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Gastritis
Figure Gastric Ulcers
Figure Duodenal Ulcers
Figure Gastroesophageal Reflux Disease (GERD)
Figure Anti-Peptic Ulcer Drugs Report Years Considered
Figure Global Anti-Peptic Ulcer Drugs Market Size 2014-2025 (Million US$)
Figure Global Anti-Peptic Ulcer Drugs Sales 2014-2025 (K MT)
Table Global Anti-Peptic Ulcer Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Anti-Peptic Ulcer Drugs Sales by Regions 2014-2019 (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Market Share by Regions 2014-2019
Figure Global Anti-Peptic Ulcer Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Anti-Peptic Ulcer Drugs Sales Market Share by Regions
Table Global Anti-Peptic Ulcer Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Anti-Peptic Ulcer Drugs Revenue Market Share by Regions 2014-2019
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Regions
Table Global Anti-Peptic Ulcer Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Anti-Peptic Ulcer Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anti-Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Anti-Peptic Ulcer Drugs Revenue Share by Manufacturers (2014-2019)
Figure Anti-Peptic Ulcer Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Anti-Peptic Ulcer Drugs Price (2014-2019) (USD/MT)
Table Anti-Peptic Ulcer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-Peptic Ulcer Drugs Product Type
Table Date of International Manufacturers Enter into Anti-Peptic Ulcer Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-Peptic Ulcer Drugs Sales by Product (2014-2019) (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Share by Product (2014-2019)
Figure Global Anti-Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure Global Anti-Peptic Ulcer Drugs Sales Market Share by Product in 2018
Table Global Anti-Peptic Ulcer Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Anti-Peptic Ulcer Drugs Revenue Share by Product (2014-2019)
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Product (2014-2019)
Figure Global Anti-Peptic Ulcer Drugs Revenue Market Share by Product in 2018
Table Anti-Peptic Ulcer Drugs Price by Product 2014-2019 (USD/MT)
Table Global Anti-Peptic Ulcer Drugs Sales by End User (2014-2019) (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Share by End User (2014-2019)
Figure Global Sales Anti-Peptic Ulcer Drugs Market Share by End User (2014-2019)
Figure Global Sales Anti-Peptic Ulcer Drugs Market Share by End User in 2018
Figure North America Anti-Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Anti-Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anti-Peptic Ulcer Drugs Sales by Countries (2014-2019) (K MT)
Table North America Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Peptic Ulcer Drugs Sales Market Share by Countries
Table North America Anti-Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries
Figure United States Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anti-Peptic Ulcer Drugs Sales by Product (2014-2019) (K MT)
Table North America Anti-Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Anti-Peptic Ulcer Drugs Market Share by Product
Table North America Anti-Peptic Ulcer Drugs Sales by End User (2014-2019) (K MT)
Table North America Anti-Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Anti-Peptic Ulcer Drugs Market Share by End User
Figure Europe Anti-Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Anti-Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anti-Peptic Ulcer Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Peptic Ulcer Drugs Sales Market Share by Countries
Table Europe Anti-Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Countries
Figure Germany Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anti-Peptic Ulcer Drugs Sales by Product (2014-2019) (K MT)
Table Europe Anti-Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anti-Peptic Ulcer Drugs Market Share by Product
Table Europe Anti-Peptic Ulcer Drugs Sales by End User (2014-2019) (K MT)
Table Europe Anti-Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anti-Peptic Ulcer Drugs Market Share by End User
Figure Asia Pacific Anti-Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Anti-Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anti-Peptic Ulcer Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Peptic Ulcer Drugs Sales Market Share by Countries
Table Asia Pacific Anti-Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Countries
Figure China Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anti-Peptic Ulcer Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Anti-Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anti-Peptic Ulcer Drugs Market Share by Product
Table Asia Pacific Anti-Peptic Ulcer Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Anti-Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anti-Peptic Ulcer Drugs Market Share by End User
Figure Central & South America Anti-Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Anti-Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anti-Peptic Ulcer Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Peptic Ulcer Drugs Sales Market Share by Countries
Table Central & South America Anti-Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-Peptic Ulcer Drugs Revenue Market Share by Countries
Figure Brazil Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anti-Peptic Ulcer Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Anti-Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anti-Peptic Ulcer Drugs Market Share by Product
Table Central & South America Anti-Peptic Ulcer Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Anti-Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anti-Peptic Ulcer Drugs Market Share by End User
Figure Middle East and Africa Anti-Peptic Ulcer Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Anti-Peptic Ulcer Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Peptic Ulcer Drugs Sales Market Share by Countries
Table Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Countries
Figure GCC Countries Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anti-Peptic Ulcer Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Anti-Peptic Ulcer Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anti-Peptic Ulcer Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Anti-Peptic Ulcer Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anti-Peptic Ulcer Drugs Market Share by Product
Table Middle East and Africa Anti-Peptic Ulcer Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Anti-Peptic Ulcer Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anti-Peptic Ulcer Drugs Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Ask-pharm Company Details
Table Ask-pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Ask-pharm Recent Development
Table Takeda Company Details
Table Takeda Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Takeda Recent Development
Table Yangtze River Pharm Company Details
Table Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Yangtze River Pharm Recent Development
Table Shandong Luoxin Company Details
Table Shandong Luoxin Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Shandong Luoxin Recent Development
Table Huadong Medicine Company Details
Table Huadong Medicine Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Huadong Medicine Recent Development
Table Changzhou Siyao Company Details
Table Changzhou Siyao Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Changzhou Siyao Recent Development
Table Beijing Yuekang Company Details
Table Beijing Yuekang Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Beijing Yuekang Recent Development
Table Guangdong Dahua Company Details
Table Guangdong Dahua Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Guangdong Dahua Recent Development
Table Xian Janssen Company Details
Table Xian Janssen Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Xian Janssen Recent Development
Table Global Anti-Peptic Ulcer Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Anti-Peptic Ulcer Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anti-Peptic Ulcer Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Anti-Peptic Ulcer Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Anti-Peptic Ulcer Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anti-Peptic Ulcer Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Anti-Peptic Ulcer Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Anti-Peptic Ulcer Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Anti-Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Anti-Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anti-Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Anti-Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anti-Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Anti-Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anti-Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Anti-Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anti-Peptic Ulcer Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anti-Peptic Ulcer Drugs Value Chain
Table Anti-Peptic Ulcer Drugs Customers List
Table Anti-Peptic Ulcer Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Esomeprazole Market Insights, Forecast to 2025
    Published: 22-Mar-2019        Price: US 3900 Onwards        Pages: 119
    The global Esomeprazole market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Esomeprazole market based on company, product type, end user and key regions. This report studies the global market size of Esomeprazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on......
  • Global Esomeprazole Market Data Survey Report 2013-2025
    Published: 19-Mar-2019        Price: US 1500 Onwards        Pages: 63
    Summary The global Esomeprazole market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on company profile, sa......
  • Global Lansoprazole Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 123
    The global Lansoprazole market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Lansoprazole market based on company, product type, end user and key regions. This report studies the global market size of Lansoprazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on......
  • Diarrhea - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 140
    Diarrhea - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Pipeline Review, H1 2019, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape. Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include......
  • Liver Cirrhosis - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 102
    Liver Cirrhosis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2019, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The scar tissue damages the normal structure of the liver which ......
  • Diabetic Gastroparesis - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 65
    Diabetic Gastroparesis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2019, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts of the bo......
  • Global Proglumide Market Status and Future Forecast 2015-2024
    Published: 11-Mar-2019        Price: US 4500 Onwards        Pages: 122
    Summary The report forecast global Proglumide market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Proglumide industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Proglumide by geography. The report splits the market size, by volume and value, on the basis of appli......
  • Global Gastrointestinal Drugs Market Data Survey Report 2013-2025
    Published: 10-Mar-2019        Price: US 1500 Onwards        Pages: 55
    Summary The global Gastrointestinal Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on company p......
  • Global Laxatives Industry Market Research Report
    Published: 07-Mar-2019        Price: US 2960 Onwards        Pages: 109
    The Laxatives market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Laxatives industrial chain, this report mainly elaborates the definition, types, applications and major players of Laxatives market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2019-20......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs